Skip to content

Ropivacaine Use in Interscalene Block; What is the Minimal Effective Analgesic Concentration (MEAC 90)

Ropivacaine Use in Interscalene Block; What is the Minimal Effective Analgesic Concentration (MEAC 90)

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04833296
Enrollment
45
Registered
2021-04-06
Start date
2021-05-01
Completion date
2021-09-30
Last updated
2021-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Brief summary

This study aim to calculate the minimal effective ropivacaine concentration required achieve successful analgesic interscalene block in 90% of patients (MEAC90)

Detailed description

* Before induction of general anesthesia, all patients will receive interscalene block using 15ml of ropivacaine which concentration will be based on the response of the previous patient. * Based on biased-coin design up-down sequential method: if patient has pain free recovery, a successful block, the next patient will be randomized to receive either the same ropivacaine concentration or a concentration 0.01% w/v less. However, if he has an unsuccessful block, the next patient will receive a concentration 0.01% w/v higher. * Patients with pain free recovery will be considered to have positive response. * Patients' responses will be analyzed to calculate the MEAC90.

Interventions

DRUGRopivacaine

all patients will receive interscalene block using same volume of ropivacaine but in different concentrations

Sponsors

Healthpoint Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients, who are scheduled for shoulder arthroscopy

Exclusion criteria

* \- \<18 y, * ASA physical class greater \>III * BMI \>40 has any contraindication for medications or techniques used in the study

Design outcomes

Primary

MeasureTime frameDescription
effective analgesic interscalene blockin recovery unit (one hour after surgery)postoperative pain (will be assessed using numerical rating scale. if ≥ 3, ineffective block will be considered and if \<3, an effective block will be considered

Countries

United Arab Emirates

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026